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Proteoglycans participate in the assembly of extracel-
lular matrix, directly by interacting with other matrix 
components and indirectly by regulating cellular 
growth-factor responses. We have studied the regu-
lation of gene expression of two small extracellular 
matrix chondroitin/dermatan sulfate proteoglycans, 
decorin and biglycan, by dexamethasone and retinoic 
acid in cultured human skin fibroblasts. Dexametha-
sone increased decorin production, maximally 4.8-
fold, and decorin mRNA levels up to 2.3-fold. but 
had no effect on biglycan production or mRNA lev-
els. Dexamethasone also prevented transforming 
growth factor-{3-elicited down-regulation of decorin 
mRNA levels and production by dermal fibroblasts. 
In addition, dexamethasone potently inhibited en-
P roteoglycans are i.ntegral components of the extracellu-lar matrix of dermal connective tissue. T I.ley participate in the assembly of extracellular matrix by interacting widl other matri-"\: components includi.ng collagens, fI-bronectin, elastic fibe rs, and hyaluronan [1-3]. R ecently, 
cloning of cDNAs for core proteins of several extracellular matri-"\: 
proteoglycans has revealed tile detailed structure of these macromol-
ecules and has helped elucidate tlleir functions [1-3]. Specifically, the 
core proteins of two small chondroitin sulfate! del11latan sulfate pro-
teoglycans-decorin and biglycan-and a ker.1tan sulfate proteogly-
can-fibromodulin-display considerable homology, demonstrated 
by the presence of several 24-amino-acid leucine-tich repeats [4-6]. 
These repeats are thought to mediate interactions of these proteogly-
cans with other matri-"\: 1110]ecules, as demonstrated by the ability of 
decOlin to bind to types I, II, and VI collagen flblils ,U1d to ftbronectin 
[1-3] . In adult hlU1lan sIGn, decorin is ablUldant t1u-oughout the denllal 
layer, especially in the papillary dermis, whereas biglycan is localized 
exclusively at tile dennoepidel111al border [7]. 
Formation of dermal extracellular matrix is regulated by various 
polypeptide growth f.,ctors [8]. The most potent stimulator of 
connective tissue formation is transforming growth factor-{3 (TGF-
{3), which plays an important role in wound repair and has also been 
implicated in the pathogenesis of dermal fibrosis [8,9]. We and 
others have shown previously that in fibrobla sts, TGF-{3 markedly 
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hancement of biglycan production and mRNA levels 
by transforming growth factor-{3. Retinoic acid dose 
dependently reduced decorin mRNA levels (by 51%) 
and production (by 72%), but had no effect on bigly-
can gene expression. Retinoic acid did not alter the 
effect of transform.ing growth factor-{3 on decorin or 
biglycan production or mRNA levels. These results 
provide evidence that the effects of glucocorticoids 
and retinoids on dermal connective tissue are par-
tially mediated via altered expression of decorin and 
biglycan, which both in turn regulate the activity of 
transforming growth factor-{3, the most potent stim-
ulator of connective tissue deposition. KeJl 1V00'ds: 
glllcocof,ticoidlproteoglJlcaulextracellllla,' matl'i."l:lt,'atfsform-
illg g,'olutll factor-{3. ] III vest De''Ina.toi 104:503-508, 1995 
enhances expression of biglycan , whereas expression of decorin is 
potently down-regulated [10-13]. However, the effects of TGF-{3 
on decorin expression appea.r to be cell specific, because in IWlg 
epithelial and IGdney mesangial cells, TGF-{3 has been shown to 
enhance expression of decorin [14,15]. Interestingly, both decorin 
and biglycan have been shown to inhibit cellular response to 
TGF-{3 by binding it with their core proteins [16,1 7]. 
Glucocorticoids are widely used to treat a variety ofinfla111l11atory 
disorders because of their potent anti-inflammatory properties. One 
of the side effects of long-term use of both systemic and topical 
glucocorticoids is dermal atrophy, mainly due to reduction in the 
amount of coll agen, the major component of dennal extracellul ar 
matrix [18] . In cell culture conditions, glucocorticoids suppress 
expression of types I and III collagen and elas tin by dermal 
fibroblasts [19 ,20]. Retinoids are used in dermatology for treatment 
of hyperprolifera tive and keratinization disorders, as well as acne. 
Retinoic acid has also been shown to stimulate formation of dermal 
connective tissue, especially type r collagen gene expression in 
photodamaged sIGn [21-23]. 
In this study, we show that decorin gene expression is potently 
stimulated by dexamethason e and suppressed by retinoic acid. In 
addition, TGF-{3-elicited suppression of decorin and enha.ncem ent 
of biglycan expression are potently inhibited by dexamethasone. 
These results suggest that the effects of glucocorticoids and retin-
oids on dermal connective tissue are partially mediated by altered 
expression of decOl;n and biglycan. 
MATERIALS AND METHODS 
CeU Cultures Human skin fibroblast cultures were established ITom 
punch biopsy specimens obtain cd fi'ol11 voluma.ry heal thy donors . The cell 
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cultures were mainta ined in Du lbecco's modification of Eagle's medium 
(DME) supplemcnted with 10'Y., feta l bovinc serum (FBS), 2 mM glu tamine, 
100 U/ml penicillin-G , and 100 J.Lg/ ml streptomycin. For RNA analysis, 
cc ll cultures were maintained for 18 h in DME supplcmentcd with 1% FBS 
in experiments with retinoic acid alone, or with 10% FBS in experiments 
with dexamethasone alone. Thereafter, dexamethasone or all-I/'n lls-retinoic 
acid (both from Sigma C hemka l Co., St. Louis, MO) was added in the 
concentrations indicated, and the incubations were continued for 24 h . In 
experiments in which TGF-/3 was used , the ccll s were first incubated for 18 
h in DME supp lemcnted with 1% FBS, and 5 ng/ml TGF-/31 or 2 (kindly 
provided by Dr. David O lsen, Celtrix Laboratories, Santa C lara, CAl was 
added to thc culture media 1 h after addition of dcxamethasone or rctinoic 
acid (1 J.LM each) . 
RNA Analysis Tota l ccllular RNA was iso lated from cell cul turcs using 
the guanidine thiocyanate /cesium chloride method (24). Aliquots of tota l 
RNA (15 J.Lg) wcre fractionatcd on 0.8,}(, agarose gels containing 2.2 M 
form aJdehyde, transfcrred to Zeta Probe fi lter (BioRad, R.ichmond, CAl by 
vacuum transfcr (VacuGcne XL; LKB , Bromma, Sweden), and immobilized 
by heating at 80°C for 30 min. Thc fi lters were prehybridized for 2 hand 
subsequently hybridizcd for 20 h with cON As labeled by [a-J2P)dCTP 
using random priming [25]. The fi l ~crs were then washed; the fina l 
stringcncy of washes was 0. '1 X standard sa line citrate/O.l % sodium 
dodecylsulfate (SDS) at 60°C for human cDNAs and 52°C for rat glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. The e2p)cDNA-
mRNA hybrids were visual.i zed by autoradiography, and the levcls of 
mRNAs were quantitated by densitometric scanning of the x-ray fi lms using 
MC ID softwarc (Imaging Research Inc., St. Catharines, Ontario, Canada). 
The following cDNAs wcre used for hybridizations: a 1.8-kilobasc pa ir (kb) 
human decorin cDNA [4] (kindly providcd by Dr. Tom Krlls iu s) , a 1.6-kb 
human biglycan cD NA [5] (kindly pro vided by Dr. Larry Fisher), a 0.7-kb 
human proal (Ill) collagcn cDNA [26] (kindly provided by Dr. Eero 
Vuorio), and a 1.3-kb rat GAPDH cDNA [27] (kindly provided by Dr. P. 
Fort). 
Proteoglycan Analysis For analys is of proteoglycan production, the 
ce ll s werc first incubated 'for 18 h in DME supp lemcnted with either 'l % FBS 
in cxpcriments with retinoi c acid and/or TGF-/3, or w ith 10% FBS in 
experimcnts w ith dexamethasonc alone. Thereafter, the cultures were 
prcincubated with dexamcthasone, retino ic acid, or TGF-/3, alone or in 
combin ations for 24 h. The incubatioll media were thell rcplaced with 
similar Incdia containing the saine conlbination of effector 1110lcc u lcs and 
]SSO. (100 J.LC i/ m l; Amersham Intcrnation;tl , Amcrshmn , UK), and the 
in cubations were continued for 48 h. 
Proteoglycans in media samples were precipitated by end-to-end uvcr-
night incubation with 20 J.LI/ m l of 50% (w/v) diethylam inoethyl (DEAE) 
Sephacel (Pharmacia LKB, Swcden) in 20 mM Tris-HCI (PH 7.5), 0. 1 % 
(w/v) T riton X-l00, and 0.15 M NaCI at 4°C. The pellets were washed 
twice with 1 ml of the same buffcr and twice with 1 ml of the buffer 
containing 0.2 M NaCI. The pcllets were then dissolved ill SDS buffcr (10 
mM sodium phosphate, pH 7.0, 2% [w/v] SDS, 10%, lv/v) glyccrol, and 
0.003%, [w/ v] Bromphenol B lue). T he optimal amount of 50% DEAE 
Scphaccl needed for precipitation of all precipitablc rad ioactivity in the 
samples was tested by using different conccntrations of 50% DEAE Sephacel 
(data not shown) . An equal vo lume from cach sam pic was boi led for 3 min 
and fractionated on SDS-polyacrylamide gel electrophoresis (PAGE) with 
4% stacking and 7.5% resolving gels [28). The gels were fi xed, enhanced, 
dri ed, and exposed to x-ray fi lms. Decorin and biglycan were identified 
based on the molecular weight as described previously [10,29,30] . T he 
relative amounts of 35SO.-labeled proteoglycans wcre quantitated by 
densitometry as mentioned above and corrected for ce ll numbers, measured 
as described previously (31) . 
RESULTS 
Dexamethasone Enhances Decorin Gene Expression by 
Dermal Fibroblasts In the initial experiment, regulation of 
d ecOl;ll gene expression by dex amethasone was studied at the level 
of proteoglycan production . Human derma l fibrob lasts were 
treated with various concentrations of dexamethasone in DME 
supple m ente d with 10% FBS a nd labeled with 35S04. Labeled 
proteoglyc3ns were precipitated with DEAE Sephacel and analyzed 
by SDS-PAGE, whic h all owed detection of decorin and biglycan 
b ased on the molec ular weight [10,29,30]. As shown ill Fig 1 , 
dexam e thasone cl early e nhan ced production of decorin in a dose-
d e pendent manner. Quantita tion of decorin levels indicated that 
the m aximal enhancement (4.8-fold) was noted with a concentra-
tion of 1 0 - 8 M (Table I) . In the sam e celJs , produc tion of biglycan 
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Figure 1. Dexamethasone enhances decorin production by dermal 
fibroblasts in culture. ConAuent cul tures of human skin fib roblasts were 
preincubated for 24 h with various concentrations of dexamethasone 
(DEXA), as indicated, in DME supplemented with 10% FBS. The cell s were 
thcn labeled with 35S0" in similar media for 48 h. T he labeled proteogly-
cans were precipitated with DEAE Scphaccl, fractionatcd on 7.5% SDS-
PAGE, and visua lized by Auorography. T he migration positions ofbiglycan 
and decorin are indicated. 
was not al tered by d exameth asone (Fig 1; Table I) . T h e relative 
mol ecular mass of decorin or b ig lycan m o lecules was pot markedly 
altered in cul tures treated w ith dexamethasone, indicating that 
under th ese condition s, dexamethasone did n ot affect the le ngth of 
the sil1gle chondroitin sulfate/ d e m1atan sul fate sid e c hain attached 
to decorin cor e protein, or of th e two cho ndroitin suJ fate/dermatan 
sul fate side c hains attached to biglycan core protein (Fig 1). 
Dexamethasone treatment of dermal fibrob lasts had no m arked 
effect on cell number (not shown) . 
To examine w hether increased production of decorin in fi bro-
blast c u ltures treated with dexame thasone was due to an increase in 
cellul ar levels of d ecorin gene transcripts, we performed Northern 
analysis with RNA fro m cell s treated w ith various con centrations of 
dexamethasone in DME contai ning 10% FBS. Inc ubation of dermal 
fibroblasts with dexamethasone clearly increased decorin mRNA 
abundan ce in a dose-dependent m anner (F ig 2). GAl)DH mRNA 
Table I. Dose-Dependent Enhancement of Decor in 
Production and mRNA Levels by Dexamethasone" 
Dexamethasone Concentration (M) 
o 
Proteoglycan production 
Decorin 4.91 8.21 18.35 23.80 18.42 14.69 
(1.00) (1.67) (3.74) (4.84) (3 .75) (2 .99) 
Biglycan 52.79 ( 62.33 60.43 55.14 52.68 48.81 
(1.00) (1.18) (1. 14) (1.04) (1.00) (0 .92) 
mRNA levels 
Dccorin 4.68 ND 7.31 10.08 10.90 9.93 
(1.00) (1.56) (2.15) (2.33) (2 .12) 
Biglycan 7.90 NO 7.20 7.46 7.86 6.52 
(1.00) (0.91) (0.94) (0. 99) (0.83) 
I I Protcogl yc~\I1 prod llction was assayed as indicated in the legend for Fig 1 . Levels 
of deco r in and big lycafl we re quantita ted by den sitometric sca nlling ofx-r4lY fi lms. The 
va_lues represent densitometric units corrected for cell numbe rs. l3 iglycan ,mel dccoriJl 
mRNA abundance was assayed as ind icated in the legend for Fig 2 and quan titated by 
dc nsitOlnctric sca nnin g of x-ray fi lms. T he v,l llI es represen t densitometric units 
corrected for GAPD H mR.NA levcls in litc same samples. T he Villucs in parentheses 
ind icate v~l lu cs re lative to the leve ls ill untreated control sam pl es (t.OO). ND. not 
detcnnined. 
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Figure 2. Dexamethasone enhances decorin mRNA levels in der-
mal fibroblasts. ConAuent human skin fibroblasts were incubated for 24 
h with various concentrations of dexamethasone (DEXA), as indicated, in 
DME supplemented with 10'l{, FBS. Aliquots of total cellular RNA (1 5 f.Lg) 
were analyzed b), Northern blot hybridizations with cD NA prob"s for 
decorin, biglycan, and GAPDH as indicated . 
levels appeared somewhat increased in cultures treated with dexa-
methasone , reflecting differences in the loading of total RNA. 
Quantitation of decOl'in mRNA levels and correction for GAPDH 
mR.NA abundance in the same samples re vealed maximal e nhance-
ment (2.3-fold) with a dexamethasone concentration of 10- 7 M 
(Table I). On the other hand, levels of big lycan mRNA were not 
markedly altered as compared with GAPDH mRNA levels in the 
sa m e samples (Fig 2, Table I). 
Retinoic Acid Suppresses Decorin Gene Expression by 
Dermal Fibroblasts Human skin fibroblasts w ere also treated 
with various concentrations of retinoic acid (ranging from 10- to to 
10 - 6 M) in DME supplemented with I'!!., FBS and labeled with 
35S04 for a period of 48 h . A nalys is oflabeled proteoglycaJ1s in the 
media re vealed that retinoic acid treatment resulted in a dose-
dependent redu ction in decOl'in production (Fig 3) . Quantitation of 
decorin production showed a maximal reduction down to 28% of 
the levels in untreated con trol cu ltures, using a concentration 
10 - 6 M (Table II). In the same media samples, production of 
biglycan was not markedly altered by retinoic acid (Fig 3, Table 
II). Treatment of skin fibroblasts with retinoic acid did not 
markedly alter cell number (not shown) . 
We also exa mined the e ffect of retinoic acid on decorin and 
biglycan mRNA levels in dermal fibroblasts using Northem blot 
hybridizations . The results show that the abundance of decorin 
gene transcripts was reduced in a dose-dependent manner by 
retinoic acid treatment of the cells (Fig 4) . Quantitatiol1 of decorin 
mRNA abundance indi cated a maximal reduction, down to 49°;(, of 
the levels in untreated control cel.ls , with a retinoic acid concen-
tration of 10 - 6 M (Table II) . Biglycan mRNA levels w ere not 
markedly alte red by retinoic acid at any of the concentrations used 
(Fig 4, Table II). 
Dexamethasone Abrogates TGF-J3-Elicited Suppression of 
Decorin Gene Expression by Dermal Fibroblasts Previ-
ously, TGF-{3 has been shown to suppress decorin gene expression 
at a pretranslationallevel by human dermal and gingival fibroblasts 
[10]. In tlus study, we also examined whethe r dexam e thasone or 
retinoic acid affects TGF-(3-elicited down-regulation of decorin 
gene expression. Analysis oe5S04 -labcled proteoglycans by SDS-
PAGE indicated that TGF-{3 (5 ng/ ml) potently reduced secretion 
of decorin into culture media, down to 36% of the levels in control 
cells, and that dexamethasone (1 f.tM) inhibited the suppression of 
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Figure 3. Retinoic acid suppresses decorin production by dermal 
fibroblasts . Confluent cultures of hUmaJl skin fibroblasts were preincu-
bated for 24 h widl various concentrations of retinoic acid (RA). as 
indicat"d , in DME containing 1 % FB5. Therea fter, the cells were labeled 
with 3550" in similar media for 48 h. The labeled prQteoglycans were 
precipitated with DEAE Sephacel, fra ctionated on 7.5% 5DS-PAGE, and 
visualized by Auorography. The migration positions of big lye all and decorill 
are indicated. 
decorin production by TGF-{3 (Fig SA,B) . On tbe other hand, 
re tinoic acid had no effect on TGF-{3-elicited dowll-regulation of 
decorin production (Fig SA,B). 
To exanune whether the inlubition ofTGF-(3-eIicited reduction 
in decorin synthesis by dexamethason e reflects alterations in 
decOl'in mRNA levels, Northe rn blot aml.lysis was also performed. 
Treatment of cells with TGF-{3 (5 ng/ml) resulted in a m arked 
reduction (down to 46'Yo ) in decorin mRNA levels (Fig 6). 
E~:posure of the cells simultaneously to dexamethasone (1 f.tM) 
a.nd TGF-{3 prevented the suppression of decorin ncRNA levels by 
TGF-{3 (Fig 6) . In contrast, retinoic acid had n o effect on the 
TGF-{3- elicited reduction in decorin mRNA leve ls (Fig 6). 
Dexamethasone Inhibits Enhancement of Biglycan Gene 
Expression by Dermal Fibroblasts Beca use dexamethasone 
potently prevented the effect ofTGF-{3 on decorin gene expressio n , 
Table II. Dose-Dependent Suppression of Decorin 
Production and mRNA Levels by Retiuoic Acid" 
R etinoic Acid Concentration (M) 
0 10- ' " 10- 9 10- " 10- 7 10- 6 
Proteoglycan production 
Decorin 51.70 51.87 41.49 45.43 19.98 14.70 
(1.00) (1.00) (0.80) (0.88) (0 .39) (0.28) 
Biglycan 32.24 29.78 26.22 37.21 43.57 41.61 
(1.00) (0.92) (0.81) (1.15) (1.35) (1.29) 
mRNA levels 
Decorin 18.55 21.09 14.41 15.86 1 2.05 9.10 
(1.00) (1.14) (0.78) (0.85) (0 .65) (0.49) 
Biglycan 7.05 10.24 8.04 9 .21 5.12 5.94 
(1.00) (1 .45) (1.14) (1.31 ) (0 .73) (0 .84) 
,/ Pro tcoglycan produ ctio n W Ol S assayed as indicated in th e legend for Fig 2 . Levels 
of dccorin and biglycan \vcrc quantit:ltcd by densitom etric scanning: of x-ray fi lms. The 
values represent densitometric tlll its corrccted for cell numbers. BiglYC3n and dccorl.l1 
ml't.NA abundancc was ass.lyed as indicated in the legend for F ig 4. and quantitated by 
dcnsitometric scanning of x-ray films. T hc values represellt" dClIsiromcrric llnits 
corrected for GA PDH mltN A Icvels ill the samc sa mples. T he va lues in parentheses 
iJ ldicate va lues relative to the levels in un treated con trol sampl es (1.00). 
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Figure 4. Retinoic acid reduces decorin mRNA abundance in 
dermal fibroblasts. ConAucnt human skin fibrob lasts wcrc incubated for 
24 h with various conccntrations ofretinoic acid (RA), as indicated, in OME 
supplemented with 1 % FBS. Aliquots of total cellular RNA (15 JLg) were 
analyzed by Northern blot hybridi zations with cONA probes for decorin, 
biglycan. and GAPOH as indicatcd. 
it was also of interest to examine whether dexamethasone can alter 
the enhancement of biglycan production and mRNA levels by 
TGF-{3 in human dermal fibroblasts . Analysis of 35S04-labeled 
proteoglycans with SDS-PAGE revea led a marked (3.8-fold) stim-
ulation of biglycan production by TGF-{3 (5 ng/ ml) (Fig 5A,B) . 
Interestingly, dexamethasone (1 fLM) partially prevented the TGF-
/3-elicited enhan cem ent of biglycan production, whereas retiJlOic 
acid had no significant effect on the up- regulation of biglycan 
synthesis by TGF-{3 (Fig 5A,B). 
In accordance with the findings above, treatment of ce lJ s with 
TGF-{3 (5 ng/ml) enhanced biglycan mRNA levels (2.3-fold), and 
simu ltaneous treatment of cell s with dexamethasone (1 fLM) and 
TGF-{3 reduced biglycan mRNA levels to th e levels in control cells 
(Fig 7) . Dexamethasone alone did not affect biglycan mRNA levels 
as compared with GAPDH mRNA levels. In addition, dexameth-
asone abolished the up-regulation (2.0-fold) of type III collagen 
mRNA levels by TGF-{3 in the same cells (Fig 7). I.n contrast to 
biglycan mRNA levels, dexamethasone alone reduced type III 
collagen mRNA abundance down to 40% of the levels in control 
cells, afte r correction for GAPDH mRNA levels in the same 
samples (Fig 7) . 
DISCUSSION 
Proteoglycans are components of extracellular matrix that inte ract 
with other matrix components Ilia both their core proteins and 
glycosaminoglycan side chain s [1,2]. In addition, extracellular 
matrix proteoglycans can regulate cellular growth-factor responses 
by iJlteracti ng with polypeptide growth factors, again with either 
their core protein or glycosaminoglycan side chains [3,32]. Specif-
ically, the extracellular matrix chondroitin sulfate/dermatan sulfate 
proteoglycans decorin and biglycan have been shown to bind 
TGF-{3 Ilia their core proteins, thus preventing binding ofTGF-{3 to 
its cell-surface receptors [1 6,17). 
In this study, we describe the effects of two therapeutica lly used 
modified hormones, dexamethasone and retinoic acid, alone and in 
combination with TGF-{3, on decorin and biglycan expression by 
dermal fibroblasts. T he results indicate that dexa methason e en-
hances decorin gene expression at the pretranslationa l leve l and 
iJ,hjbits TGF-/3-elicited suppression of decorin gene expression as 
well as up-regul ation of big lycan gene expression in human dermal 
fibroblasts. Retinoic acid, in turn, potently inhjbits decorin gene 
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Figure 5. Dexamcthasonc prcvcnts TGF-{3-clicitcd down-regula-
tion of decorill production and enhancement of biglycall produc-
tion by dcrmal fibroblasts. A) ConAucnt cultures of human skin 
fibrob lasts were preincubated for 24 h with TGF-/32 (5 ng/ ml) alone or in 
combination with dexamethasone (OEXA) or retinoic acid (R.A) (both 1 
JLM), as indicatcd, in OME containing 1 % FBS. The cell s wcre chen labeled 
with 35S0" in similar media for 48 h. The labeled proteoglycal1S were 
precipitated w ith OEAE Scphacel, fractiom'ted on SOS-PAGE, and visua l-
izcd by Auorography. T he migration positions of biglycan and decorin arc 
indicated . B) Oecorin (solid bars) and biglycan (s ltaded bars) protcoglycan 
(PG) production was quantitatcd by scanning dcnsitomctry of x-ray films. 
The data represent 111can ± SEM frol11 three independent cXpCrit11cnts. The 
decori n and biglycan production ratcs for cach expcriment were corrected 
for cell number and calculatcd relative to the levels in untreatcd control 
samples (1.00). OX, dexamethasone. 
( 
expression, but has no efFect on expression of biglycan or on the 
effect of TGF-{3 on biglycan and decorin gene expression . 
Glucocorticoids potently suppress expression of types I and HI 
co lJ agens, as well as e la stin, by dermal fibroblasts at the posttran-
scriptiona l level [18-20] . It is possible that the enhancing effect of 
dexamethasone on decorin gene expression takes place at the 
transcriptional level. The ava.ilable nucleotide sequence of the 
5' -Ranking region of the human decorin gene does not contanl 
g lucocorticoid- responsive elements required for activation of tran-
scription by g lucocorticoids [33]. Such e lements may, however, 
reside outside the regulatory sequences currently available. Re-
VOL. 104. NO.4 APIUL 1995 
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Figure 6. Dexamethasone inhibits TGF-J3-clicitcd down-regula-
tion of dccorin InRNA lcvcls. Confluent human skin fibroblasts were 
incubated for 24 h with TGF-J32 (5 ng/ml) alone or in combination with 
dexamethasone (DEXA) (1 iJ-M) or retinoic acid (RA) (1 iJ-M) , as inclicated, 
in DME supplemented with 1% FRS. Thereafter, aliquots (15 iJ-g) of total 
cellular RNA were analyzed by Northern blot hybridizations using cDNA 
probes for decorin and GAPDH. 
gardless of the a.ctivation n~echanism, it is co.nc~ivable that stim~­
lation of deconn production by glucocortICOlds may result 111 
inhibition of the cellulaI' TGF-,B response, which further potentiates 
the inhibitory effects of glucocorticoids on the expression of 
connective tissue genes, such as those for types I and III collagen 
aI1d elastin, which are susceptible to activation by TGF-,B [8]. 
The role of excessive accumulation of decOl'in in the pathogen-
esis of glomerulosclerosis in experimentally induced glomerulone-
phritis in rats has been U11~qui~oc~y demonstrated [34]. Activation 
of decorin gene expressIOn 111 tlus fibrOSIS model appears to be 
mediated by TGF-,B, because neutralizing antibodies against TGF-,B 
can prevent accumulation of decOl'in and subsequent glomerulo-
sclerosis [35] . In another model of tissue fibrosis, bleomycin-
DEXA 
TGF-pl 
proal (III) 
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-
-
-
+ 
+ 
+ 
+ 
Figure 7. Dcxamcthasonc prcvcnts enhancclncnt of biglycan 
mRNA lcvcls by TGF-f3 in dcrmal fibroblasts. Confluent human skin 
fibroblasts were incubated for 24 h with TGF-J31 (5 ng/ml) or with 
dexamethasone (DEXA) (1 iJ-M) "Ionc or in combination , as indicated, in 
DME supplemented with 1% FBS. Aliquots (15 iJ-g) of total cellular RNA 
were analyzed by Northern blot hybridizations with cDNA probes for 
proal (III) collagcn, biglycan, and GAPDH. 
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induced pulmonary fibrosis in rats, enhanced expression ofbiglycan 
gene has been documented, whereas expression of deconn was not 
altered [36]. In addition, in fibroblasts cultured from the lesional 
skin of patients with systemic or localized scleroderma, expression 
of decorin mRNA was not increased in cells expressin g elevated 
levels of type I collagen mRNA, indicating that decorin gene 
expression is not enhanced in dermal fibrosis [37]. The expression 
ofbiglycan in dermal fibrosis has not been examined, but it is likely 
that enhanced deposition of biglycan may also contribute to the 
formation of fibrotic dermal extracellular matri.x in disorders such 
as scleroderma and keloids. 
Glucocorticoids have been shown to inhibit the formation of new 
connective tissue in a rat w0U11d-healing model [38,39] . The results 
of this study suggest that the aI1tifibrotic effect of glucocorticoids 
may also be indirectly mediated by increased production of deconn , 
which in tum may inhibit binding of TGF-,B to fibroblasts. Tlus 
effect may be potentiated further by inhibition of TGF-,B-elicited 
suppression of decorin expression. It is also conceivable that 
increased production of decorin by fibroblasts treated with glu-
cocorticoids results in the formation of looser collagenous matri.x 
because of inlubition of type I collagen fibril formation by deconn 
[1,2]. 
Retinoic acid has been shown to stimulate the formation of 
dermal extracellular matrix, especially deposition of type I collagen 
in the upper dermal laye r of photo damaged skin [21-23]. TillS may 
be due to retinoic-acid-elicited enhaI1cement of expression of 
TGF-,B1 and 2 by epidermal keratinocytes [23 ,40]. The results of 
the present study suggest that the enhaI1.cing effect of retinoic acid 
on del111al cOlU1ective tissue may also be potentiated Ilia reduced 
production of decorin, which results in increased availability ofTGF-{3 
in the deonal extracellular milieu. These resu.lts are in accordance with 
earlier observations indicating reduction of decorin mRNA levels in 
de\111al fibroblasts by 13-cis-retinoic acid [41]. 
In conclusion , the results of tills study indicate tl1at decorin 
expression and biglycan expression are effectively but differentially 
regulated by glucocorticoids and retinoids. These observations 
suggest that the efFects of glucocorticoids aIld retinoids on dermal 
connective tissue may also be partially m ediated Ilia altered depo-
sition of extracellular matrix pl'Oteoglycans, especially decorin. 
These findings also provide prospects for development of novel 
therapeutic strategies for disorders charac tetized by tissue fibrosis. 
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